New York State will provide a $5 million funding grant to assist The Trudeau Institute with its biomedical research at its campus in Saranac Lake, New York
The Trudeau Institute, a world-renowned center for immunological research, will use the grant of up to $5 million for a portion of the costs of ongoing programs, operations, and staffing at Trudeau biomedical research laboratories. The Institute will continue to operate and expand its research laboratory to conduct biomedical research in New York State including aging, cancer, influenza, pneumonia, tuberculosis, acquired immune deficiency syndrome, and Lyme disease.
Trudeau will also expand its existing contract research capabilities for pharmaceutical, biotechnology and biomedical engineering companies, leveraging its expertise and world-class experimental animal facilities and unique CDC-certified laboratories for investigating immunity to Select Agent pathogens for biodefense.
“This investment by New York State supporting the strategic alliance between Clarkson University and Trudeau Institute will leverage complementary strengths of our faculties. The partnership covers the full range of biotechnology including biomedical life science research and engineering sciences with entrepreneurialism,” said Ronald H. Goldfarb, President, Director and CEO of the Trudeau Institute. “We are very excited that our collaboration represents novel approaches towards technical innovation and education. Our synergistic expertise will further cultivate the emerging biotechnology industry as an engine for economic development and the creation of new jobs in the North Country.”
This multi-year project, in conjunction with partnerships with Clarkson University and the State, will move the Trudeau Institute closer to its broader vision of developing a biotechnology cluster in the North Country. The Institute and Clarkson will establish and coordinate scientific research and expand education and technology-based economic development. Trudeau and Clarkson will also put in place the faculty, facilities, and educational programs to make this cluster self-sustaining and diversify and develop other funding and business opportunities to sustain a new business model for future operations.
Gov. Andrew Cuomo
said the Institute will establish New York’s North Country region as a premier center of biotechnology research and development. The initiative will attract new investment, save approximately 80 jobs at the Trudeau Institute, and encourage the commercialization of new technologies that will lead to creation of new companies and bring hundreds of jobs.
"I’m pleased to announce that today’s first round of funding officially moves the joint-venture between Clarkson University and the Trudeau Institute forward," Governor Cuomo said. "This partnership harnesses the assets of the North Country to position the region as a premier destination for the growing biotech field, creating jobs and bolstering this industry in the region. As we work to make New York State a capital of innovation, this initiative will help spur the commercialization process, build new opportunities in the industry and create good jobs for the North Country."
“Under the Governor’s leadership, we are making strategic investments in high-tech industries to grow jobs and spur additional investment across the State,” said Empire State Development
President, CEO and Commissioner Kenneth Adams. “Through the State’s commitment to the Clarkson-Trudeau partnership, we are not only supporting the North Country’s emerging biotech cluster, but also delivering on the Governor’s promise to capitalize on the State’s leadership in innovation and move products from the laboratory to commercialization, which will to generate high paying jobs in the North Country.”
“Clarkson University and the Trudeau Institute greatly appreciate the opportunity to move quickly to develop the emerging biotech partnership between both entities,” said Tony Collins, President of Clarkson University. “The Governor and New York State are truly jump starting this venture.”